Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

High Performance Epoxy Market

ID: MRFR/CnM/1630-HCR
135 Pages
Chitranshi Jaiswal
Last Updated: April 06, 2026

High-Performance Epoxy Market Research Report Information by Grade (Industrial, Food, and Others), by End Use (Electronics, Packaging, Construction, Medical, Transportation, and Others), Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa)—Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

High Performance Epoxy Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Chemicals and Materials, BY Application (USD Billion)
  49.     4.1.1 Aerospace
  50.     4.1.2 Automotive
  51.     4.1.3 Electronics
  52.     4.1.4 Construction
  53.     4.1.5 Marine
  54.   4.2 Chemicals and Materials, BY End Use (USD Billion)
  55.     4.2.1 Adhesives
  56.     4.2.2 Coatings
  57.     4.2.3 Composites
  58.     4.2.4 Sealants
  59.     4.2.5 Encapsulants
  60.   4.3 Chemicals and Materials, BY Formulation Type (USD Billion)
  61.     4.3.1 Two-Part Epoxy
  62.     4.3.2 One-Part Epoxy
  63.     4.3.3 Modified Epoxy
  64.     4.3.4 High-Temperature Epoxy
  65.     4.3.5 Low-Viscosity Epoxy
  66.   4.4 Chemicals and Materials, BY Curing Mechanism (USD Billion)
  67.     4.4.1 Thermal Curing
  68.     4.4.2 UV Curing
  69.     4.4.3 Moisture Curing
  70.     4.4.4 Chemical Curing
  71.     4.4.5 Room Temperature Curing
  72.   4.5 Chemicals and Materials, BY Region (USD Billion)
  73.     4.5.1 North America
  74.       4.5.1.1 US
  75.       4.5.1.2 Canada
  76.     4.5.2 Europe
  77.       4.5.2.1 Germany
  78.       4.5.2.2 UK
  79.       4.5.2.3 France
  80.       4.5.2.4 Russia
  81.       4.5.2.5 Italy
  82.       4.5.2.6 Spain
  83.       4.5.2.7 Rest of Europe
  84.     4.5.3 APAC
  85.       4.5.3.1 China
  86.       4.5.3.2 India
  87.       4.5.3.3 Japan
  88.       4.5.3.4 South Korea
  89.       4.5.3.5 Malaysia
  90.       4.5.3.6 Thailand
  91.       4.5.3.7 Indonesia
  92.       4.5.3.8 Rest of APAC
  93.     4.5.4 South America
  94.       4.5.4.1 Brazil
  95.       4.5.4.2 Mexico
  96.       4.5.4.3 Argentina
  97.       4.5.4.4 Rest of South America
  98.     4.5.5 MEA
  99.       4.5.5.1 GCC Countries
  100.       4.5.5.2 South Africa
  101.       4.5.5.3 Rest of MEA
  102. 5 SECTION V: COMPETITIVE ANALYSIS
  103.   5.1 Competitive Landscape
  104.     5.1.1 Overview
  105.     5.1.2 Competitive Analysis
  106.     5.1.3 Market share Analysis
  107.     5.1.4 Major Growth Strategy in the Chemicals and Materials
  108.     5.1.5 Competitive Benchmarking
  109.     5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  110.     5.1.7 Key developments and growth strategies
  111.       5.1.7.1 New Product Launch/Service Deployment
  112.       5.1.7.2 Merger & Acquisitions
  113.       5.1.7.3 Joint Ventures
  114.     5.1.8 Major Players Financial Matrix
  115.       5.1.8.1 Sales and Operating Income
  116.       5.1.8.2 Major Players R&D Expenditure. 2023
  117.   5.2 Company Profiles
  118.     5.2.1 Huntsman Corporation (US)
  119.       5.2.1.1 Financial Overview
  120.       5.2.1.2 Products Offered
  121.       5.2.1.3 Key Developments
  122.       5.2.1.4 SWOT Analysis
  123.       5.2.1.5 Key Strategies
  124.     5.2.2 BASF SE (DE)
  125.       5.2.2.1 Financial Overview
  126.       5.2.2.2 Products Offered
  127.       5.2.2.3 Key Developments
  128.       5.2.2.4 SWOT Analysis
  129.       5.2.2.5 Key Strategies
  130.     5.2.3 3M Company (US)
  131.       5.2.3.1 Financial Overview
  132.       5.2.3.2 Products Offered
  133.       5.2.3.3 Key Developments
  134.       5.2.3.4 SWOT Analysis
  135.       5.2.3.5 Key Strategies
  136.     5.2.4 Sika AG (CH)
  137.       5.2.4.1 Financial Overview
  138.       5.2.4.2 Products Offered
  139.       5.2.4.3 Key Developments
  140.       5.2.4.4 SWOT Analysis
  141.       5.2.4.5 Key Strategies
  142.     5.2.5 Henkel AG & Co. KGaA (DE)
  143.       5.2.5.1 Financial Overview
  144.       5.2.5.2 Products Offered
  145.       5.2.5.3 Key Developments
  146.       5.2.5.4 SWOT Analysis
  147.       5.2.5.5 Key Strategies
  148.     5.2.6 Momentive Performance Materials Inc. (US)
  149.       5.2.6.1 Financial Overview
  150.       5.2.6.2 Products Offered
  151.       5.2.6.3 Key Developments
  152.       5.2.6.4 SWOT Analysis
  153.       5.2.6.5 Key Strategies
  154.     5.2.7 Dow Inc. (US)
  155.       5.2.7.1 Financial Overview
  156.       5.2.7.2 Products Offered
  157.       5.2.7.3 Key Developments
  158.       5.2.7.4 SWOT Analysis
  159.       5.2.7.5 Key Strategies
  160.     5.2.8 Lord Corporation (US)
  161.       5.2.8.1 Financial Overview
  162.       5.2.8.2 Products Offered
  163.       5.2.8.3 Key Developments
  164.       5.2.8.4 SWOT Analysis
  165.       5.2.8.5 Key Strategies
  166.     5.2.9 Mitsubishi Chemical Corporation (JP)
  167.       5.2.9.1 Financial Overview
  168.       5.2.9.2 Products Offered
  169.       5.2.9.3 Key Developments
  170.       5.2.9.4 SWOT Analysis
  171.       5.2.9.5 Key Strategies
  172.     5.2.10 Covestro AG (DE)
  173.       5.2.10.1 Financial Overview
  174.       5.2.10.2 Products Offered
  175.       5.2.10.3 Key Developments
  176.       5.2.10.4 SWOT Analysis
  177.       5.2.10.5 Key Strategies
  178.   5.3 Appendix
  179.     5.3.1 References
  180.     5.3.2 Related Reports
  181. 6 LIST OF FIGURES
  182.   6.1 MARKET SYNOPSIS
  183.   6.2 NORTH AMERICA MARKET ANALYSIS
  184.   6.3 US MARKET ANALYSIS BY APPLICATION
  185.   6.4 US MARKET ANALYSIS BY END USE
  186.   6.5 US MARKET ANALYSIS BY FORMULATION TYPE
  187.   6.6 US MARKET ANALYSIS BY CURING MECHANISM
  188.   6.7 CANADA MARKET ANALYSIS BY APPLICATION
  189.   6.8 CANADA MARKET ANALYSIS BY END USE
  190.   6.9 CANADA MARKET ANALYSIS BY FORMULATION TYPE
  191.   6.10 CANADA MARKET ANALYSIS BY CURING MECHANISM
  192.   6.11 EUROPE MARKET ANALYSIS
  193.   6.12 GERMANY MARKET ANALYSIS BY APPLICATION
  194.   6.13 GERMANY MARKET ANALYSIS BY END USE
  195.   6.14 GERMANY MARKET ANALYSIS BY FORMULATION TYPE
  196.   6.15 GERMANY MARKET ANALYSIS BY CURING MECHANISM
  197.   6.16 UK MARKET ANALYSIS BY APPLICATION
  198.   6.17 UK MARKET ANALYSIS BY END USE
  199.   6.18 UK MARKET ANALYSIS BY FORMULATION TYPE
  200.   6.19 UK MARKET ANALYSIS BY CURING MECHANISM
  201.   6.20 FRANCE MARKET ANALYSIS BY APPLICATION
  202.   6.21 FRANCE MARKET ANALYSIS BY END USE
  203.   6.22 FRANCE MARKET ANALYSIS BY FORMULATION TYPE
  204.   6.23 FRANCE MARKET ANALYSIS BY CURING MECHANISM
  205.   6.24 RUSSIA MARKET ANALYSIS BY APPLICATION
  206.   6.25 RUSSIA MARKET ANALYSIS BY END USE
  207.   6.26 RUSSIA MARKET ANALYSIS BY FORMULATION TYPE
  208.   6.27 RUSSIA MARKET ANALYSIS BY CURING MECHANISM
  209.   6.28 ITALY MARKET ANALYSIS BY APPLICATION
  210.   6.29 ITALY MARKET ANALYSIS BY END USE
  211.   6.30 ITALY MARKET ANALYSIS BY FORMULATION TYPE
  212.   6.31 ITALY MARKET ANALYSIS BY CURING MECHANISM
  213.   6.32 SPAIN MARKET ANALYSIS BY APPLICATION
  214.   6.33 SPAIN MARKET ANALYSIS BY END USE
  215.   6.34 SPAIN MARKET ANALYSIS BY FORMULATION TYPE
  216.   6.35 SPAIN MARKET ANALYSIS BY CURING MECHANISM
  217.   6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  218.   6.37 REST OF EUROPE MARKET ANALYSIS BY END USE
  219.   6.38 REST OF EUROPE MARKET ANALYSIS BY FORMULATION TYPE
  220.   6.39 REST OF EUROPE MARKET ANALYSIS BY CURING MECHANISM
  221.   6.40 APAC MARKET ANALYSIS
  222.   6.41 CHINA MARKET ANALYSIS BY APPLICATION
  223.   6.42 CHINA MARKET ANALYSIS BY END USE
  224.   6.43 CHINA MARKET ANALYSIS BY FORMULATION TYPE
  225.   6.44 CHINA MARKET ANALYSIS BY CURING MECHANISM
  226.   6.45 INDIA MARKET ANALYSIS BY APPLICATION
  227.   6.46 INDIA MARKET ANALYSIS BY END USE
  228.   6.47 INDIA MARKET ANALYSIS BY FORMULATION TYPE
  229.   6.48 INDIA MARKET ANALYSIS BY CURING MECHANISM
  230.   6.49 JAPAN MARKET ANALYSIS BY APPLICATION
  231.   6.50 JAPAN MARKET ANALYSIS BY END USE
  232.   6.51 JAPAN MARKET ANALYSIS BY FORMULATION TYPE
  233.   6.52 JAPAN MARKET ANALYSIS BY CURING MECHANISM
  234.   6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  235.   6.54 SOUTH KOREA MARKET ANALYSIS BY END USE
  236.   6.55 SOUTH KOREA MARKET ANALYSIS BY FORMULATION TYPE
  237.   6.56 SOUTH KOREA MARKET ANALYSIS BY CURING MECHANISM
  238.   6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION
  239.   6.58 MALAYSIA MARKET ANALYSIS BY END USE
  240.   6.59 MALAYSIA MARKET ANALYSIS BY FORMULATION TYPE
  241.   6.60 MALAYSIA MARKET ANALYSIS BY CURING MECHANISM
  242.   6.61 THAILAND MARKET ANALYSIS BY APPLICATION
  243.   6.62 THAILAND MARKET ANALYSIS BY END USE
  244.   6.63 THAILAND MARKET ANALYSIS BY FORMULATION TYPE
  245.   6.64 THAILAND MARKET ANALYSIS BY CURING MECHANISM
  246.   6.65 INDONESIA MARKET ANALYSIS BY APPLICATION
  247.   6.66 INDONESIA MARKET ANALYSIS BY END USE
  248.   6.67 INDONESIA MARKET ANALYSIS BY FORMULATION TYPE
  249.   6.68 INDONESIA MARKET ANALYSIS BY CURING MECHANISM
  250.   6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION
  251.   6.70 REST OF APAC MARKET ANALYSIS BY END USE
  252.   6.71 REST OF APAC MARKET ANALYSIS BY FORMULATION TYPE
  253.   6.72 REST OF APAC MARKET ANALYSIS BY CURING MECHANISM
  254.   6.73 SOUTH AMERICA MARKET ANALYSIS
  255.   6.74 BRAZIL MARKET ANALYSIS BY APPLICATION
  256.   6.75 BRAZIL MARKET ANALYSIS BY END USE
  257.   6.76 BRAZIL MARKET ANALYSIS BY FORMULATION TYPE
  258.   6.77 BRAZIL MARKET ANALYSIS BY CURING MECHANISM
  259.   6.78 MEXICO MARKET ANALYSIS BY APPLICATION
  260.   6.79 MEXICO MARKET ANALYSIS BY END USE
  261.   6.80 MEXICO MARKET ANALYSIS BY FORMULATION TYPE
  262.   6.81 MEXICO MARKET ANALYSIS BY CURING MECHANISM
  263.   6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION
  264.   6.83 ARGENTINA MARKET ANALYSIS BY END USE
  265.   6.84 ARGENTINA MARKET ANALYSIS BY FORMULATION TYPE
  266.   6.85 ARGENTINA MARKET ANALYSIS BY CURING MECHANISM
  267.   6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  268.   6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
  269.   6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION TYPE
  270.   6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY CURING MECHANISM
  271.   6.90 MEA MARKET ANALYSIS
  272.   6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  273.   6.92 GCC COUNTRIES MARKET ANALYSIS BY END USE
  274.   6.93 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION TYPE
  275.   6.94 GCC COUNTRIES MARKET ANALYSIS BY CURING MECHANISM
  276.   6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  277.   6.96 SOUTH AFRICA MARKET ANALYSIS BY END USE
  278.   6.97 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION TYPE
  279.   6.98 SOUTH AFRICA MARKET ANALYSIS BY CURING MECHANISM
  280.   6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION
  281.   6.100 REST OF MEA MARKET ANALYSIS BY END USE
  282.   6.101 REST OF MEA MARKET ANALYSIS BY FORMULATION TYPE
  283.   6.102 REST OF MEA MARKET ANALYSIS BY CURING MECHANISM
  284.   6.103 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
  285.   6.104 RESEARCH PROCESS OF MRFR
  286.   6.105 DRO ANALYSIS OF CHEMICALS AND MATERIALS
  287.   6.106 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  288.   6.107 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  289.   6.108 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
  290.   6.109 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
  291.   6.110 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Billion)
  292.   6.111 CHEMICALS AND MATERIALS, BY END USE, 2024 (% SHARE)
  293.   6.112 CHEMICALS AND MATERIALS, BY END USE, 2024 TO 2035 (USD Billion)
  294.   6.113 CHEMICALS AND MATERIALS, BY FORMULATION TYPE, 2024 (% SHARE)
  295.   6.114 CHEMICALS AND MATERIALS, BY FORMULATION TYPE, 2024 TO 2035 (USD Billion)
  296.   6.115 CHEMICALS AND MATERIALS, BY CURING MECHANISM, 2024 (% SHARE)
  297.   6.116 CHEMICALS AND MATERIALS, BY CURING MECHANISM, 2024 TO 2035 (USD Billion)
  298.   6.117 BENCHMARKING OF MAJOR COMPETITORS
  299. 7 LIST OF TABLES
  300.   7.1 LIST OF ASSUMPTIONS
  301.     7.1.1
  302.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  303.     7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
  304.     7.2.2 BY END USE, 2025-2035 (USD Billion)
  305.     7.2.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  306.     7.2.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  307.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  308.     7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
  309.     7.3.2 BY END USE, 2025-2035 (USD Billion)
  310.     7.3.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  311.     7.3.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  312.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  313.     7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
  314.     7.4.2 BY END USE, 2025-2035 (USD Billion)
  315.     7.4.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  316.     7.4.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  317.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  318.     7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
  319.     7.5.2 BY END USE, 2025-2035 (USD Billion)
  320.     7.5.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  321.     7.5.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  322.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  323.     7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
  324.     7.6.2 BY END USE, 2025-2035 (USD Billion)
  325.     7.6.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  326.     7.6.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  327.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  328.     7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
  329.     7.7.2 BY END USE, 2025-2035 (USD Billion)
  330.     7.7.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  331.     7.7.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  332.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  333.     7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
  334.     7.8.2 BY END USE, 2025-2035 (USD Billion)
  335.     7.8.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  336.     7.8.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  337.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  338.     7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
  339.     7.9.2 BY END USE, 2025-2035 (USD Billion)
  340.     7.9.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  341.     7.9.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  342.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  343.     7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
  344.     7.10.2 BY END USE, 2025-2035 (USD Billion)
  345.     7.10.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  346.     7.10.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  347.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  348.     7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
  349.     7.11.2 BY END USE, 2025-2035 (USD Billion)
  350.     7.11.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  351.     7.11.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  352.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  353.     7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
  354.     7.12.2 BY END USE, 2025-2035 (USD Billion)
  355.     7.12.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  356.     7.12.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  357.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  358.     7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
  359.     7.13.2 BY END USE, 2025-2035 (USD Billion)
  360.     7.13.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  361.     7.13.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  362.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  363.     7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
  364.     7.14.2 BY END USE, 2025-2035 (USD Billion)
  365.     7.14.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  366.     7.14.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  367.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  368.     7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
  369.     7.15.2 BY END USE, 2025-2035 (USD Billion)
  370.     7.15.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  371.     7.15.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  372.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  373.     7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
  374.     7.16.2 BY END USE, 2025-2035 (USD Billion)
  375.     7.16.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  376.     7.16.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  377.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  378.     7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
  379.     7.17.2 BY END USE, 2025-2035 (USD Billion)
  380.     7.17.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  381.     7.17.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  382.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  383.     7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
  384.     7.18.2 BY END USE, 2025-2035 (USD Billion)
  385.     7.18.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  386.     7.18.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  387.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  388.     7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
  389.     7.19.2 BY END USE, 2025-2035 (USD Billion)
  390.     7.19.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  391.     7.19.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  392.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  393.     7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
  394.     7.20.2 BY END USE, 2025-2035 (USD Billion)
  395.     7.20.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  396.     7.20.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  397.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  398.     7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
  399.     7.21.2 BY END USE, 2025-2035 (USD Billion)
  400.     7.21.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  401.     7.21.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  402.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  403.     7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
  404.     7.22.2 BY END USE, 2025-2035 (USD Billion)
  405.     7.22.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  406.     7.22.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  407.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  408.     7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
  409.     7.23.2 BY END USE, 2025-2035 (USD Billion)
  410.     7.23.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  411.     7.23.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  412.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  413.     7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
  414.     7.24.2 BY END USE, 2025-2035 (USD Billion)
  415.     7.24.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  416.     7.24.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  417.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  418.     7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
  419.     7.25.2 BY END USE, 2025-2035 (USD Billion)
  420.     7.25.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  421.     7.25.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  422.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  423.     7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
  424.     7.26.2 BY END USE, 2025-2035 (USD Billion)
  425.     7.26.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  426.     7.26.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  427.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  428.     7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
  429.     7.27.2 BY END USE, 2025-2035 (USD Billion)
  430.     7.27.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  431.     7.27.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  432.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  433.     7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
  434.     7.28.2 BY END USE, 2025-2035 (USD Billion)
  435.     7.28.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  436.     7.28.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  437.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  438.     7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
  439.     7.29.2 BY END USE, 2025-2035 (USD Billion)
  440.     7.29.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  441.     7.29.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  442.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  443.     7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
  444.     7.30.2 BY END USE, 2025-2035 (USD Billion)
  445.     7.30.3 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  446.     7.30.4 BY CURING MECHANISM, 2025-2035 (USD Billion)
  447.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  448.     7.31.1
  449.   7.32 ACQUISITION/PARTNERSHIP
  450.     7.32.1

Chemicals and Materials Market Segmentation

Chemicals and Materials By Application (USD Billion, 2025-2035)

  • Aerospace
  • Automotive
  • Electronics
  • Construction
  • Marine

Chemicals and Materials By End Use (USD Billion, 2025-2035)

  • Adhesives
  • Coatings
  • Composites
  • Sealants
  • Encapsulants

Chemicals and Materials By Formulation Type (USD Billion, 2025-2035)

  • Two-Part Epoxy
  • One-Part Epoxy
  • Modified Epoxy
  • High-Temperature Epoxy
  • Low-Viscosity Epoxy

Chemicals and Materials By Curing Mechanism (USD Billion, 2025-2035)

  • Thermal Curing
  • UV Curing
  • Moisture Curing
  • Chemical Curing
  • Room Temperature Curing

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions